Drug bill with exemptions for LTC pharmacies heads to Obama
A bill that would exempt long-term care pharmacies from a controversial “lock-in” provision received final passage from the Senate on Wednesday and now heads to the president’s desk.
The Comprehensive Addiction and Recovery Act includes language that would require Medicare Part D beneficiaries to use one pharmacy for all prescriptions, in an effort to lessen opioid abuse.
Long-term care pharmacy advocates condemned the “lock-in” clause, arguing that legislation already existed that protected beneficiaries in long-term care settings from drug abuse. Alan Rosenbloom, president of the Senior Care Pharmacy Coalition, praised the passage of the bill with the LTC exemption intact.
“The exemption is a vital provision that specifically recognizes the unique characteristics of the long-term care patient population and the distinctions between specialized long-term care pharmacies and more well-known retail pharmacies — particularly the additional requirements already imposed on LTC pharmacies under Medicare and Medicaid Requirements of Participation and Medicare Part D rules,” Rosenbloom said
Long-term care pharmacies’ tracking, auditing, packaging and dispensing of drugs helps them meet the “extraordinarily high” safety standards for Medicare Part D, Rosenbloom said. He also stressed the fact that pharmacists and licensed facility staff are the ones handling the prescription orders, not the beneficiaries themselves.
“CARA strikes the right balance between protecting our citizens and communities on the one hand, and protecting the ability of LTC pharmacies to meet and manage the medication needs of LTC residents on the other,” Rosenbloom said.
Obama is expected to sign the bill. CARA is estimated to receive $581 million in funding, which is set to be authorized by Senate Republicans in September after Congress’ summer recess.
Click here to see the original article on the McKnight’s website.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.